A correctable immune niche for epithelial stem cell reprogramming and post-viral lung diseases

J Clin Invest. 2024 Jul 25;134(18):e183092. doi: 10.1172/JCI183092.

Abstract

Epithelial barriers are programmed for defense and repair but are also the site of long-term structural remodeling and disease. In general, this paradigm features epithelial stem cells (ESCs) that are called on to regenerate damaged tissues but can also be reprogrammed for detrimental remodeling. Here we identified a Wfdc21-dependent monocyte-derived dendritic cell (moDC) population that functioned as an early sentinel niche for basal ESC reprogramming in mouse models of epithelial injury after respiratory viral infection. Niche function depended on moDC delivery of ligand GPNMB to the basal ESC receptor CD44 so that properly timed antibody blockade of ligand or receptor provided long-lasting correction of reprogramming and broad disease phenotypes. These same control points worked directly in mouse and human basal ESC organoids. Together, the findings identify a mechanism to explain and modify what is otherwise a stereotyped but sometimes detrimental response to epithelial injury.

Keywords: Adult stem cells; Influenza; Pulmonology; Respiration.

MeSH terms

  • Animals
  • Cellular Reprogramming* / immunology
  • Dendritic Cells / immunology
  • Epithelial Cells / immunology
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Humans
  • Hyaluronan Receptors / genetics
  • Hyaluronan Receptors / immunology
  • Hyaluronan Receptors / metabolism
  • Lung Diseases / immunology
  • Lung Diseases / metabolism
  • Lung Diseases / pathology
  • Membrane Glycoproteins / immunology
  • Membrane Glycoproteins / metabolism
  • Mice
  • Stem Cell Niche / immunology
  • Stem Cells / immunology
  • Stem Cells / metabolism

Substances

  • Hyaluronan Receptors
  • Membrane Glycoproteins
  • Cd44 protein, mouse
  • CD44 protein, human